Comparative Pharmacology
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus VAGIFEM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIETHYLSTILBESTROL versus VAGIFEM.
DIETHYLSTILBESTROL vs VAGIFEM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that binds to estrogen receptors (ERα/ERβ), activating estrogen-responsive gene transcription, leading to proliferation of estrogen-sensitive tissues.
Estradiol is a form of estrogen that binds to estrogen receptors, activating gene transcription and leading to various physiological effects. It replaces endogenous estrogen in postmenopausal women, alleviating symptoms of vaginal atrophy.
0.5-2 mg orally once daily for palliative treatment of advanced prostate cancer; 5-15 mg orally once daily for prevention of postpartum breast engorgement.
One vaginal tablet (10 mcg estradiol) inserted daily for 2 weeks, then maintenance of one tablet twice weekly.
None Documented
None Documented
Clinical Note
moderateDiethylstilbestrol + Digoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digoxin."
Clinical Note
moderateDiethylstilbestrol + Digitoxin
"Diethylstilbestrol may decrease the cardiotoxic activities of Digitoxin."
Clinical Note
moderateDiethylstilbestrol + Deslanoside
"Diethylstilbestrol may decrease the cardiotoxic activities of Deslanoside."
Clinical Note
moderateDiethylstilbestrol + Acetyldigitoxin
Terminal elimination half-life is approximately 24 hours (range 20-30 hours) in adults; prolonged in hepatic impairment.
The terminal elimination half-life of estradiol is approximately 2-3 hours. Due to enterohepatic recirculation, the effective half-life may be longer, and daily dosing maintains steady-state concentrations.
Primarily renal (90% as glucuronide and sulfate conjugates), with less than 5% excreted unchanged in urine; biliary/fecal elimination accounts for about 10%.
Vagifem (estradiol) undergoes hepatic metabolism and renal excretion. Approximately 60-80% of a dose is excreted in urine as glucuronide and sulfate conjugates, with about 10-15% excreted in feces via biliary elimination. Unchanged estradiol is minimally excreted.
Category C
Category C
Estrogen
Estrogen
"Diethylstilbestrol may decrease the cardiotoxic activities of Acetyldigitoxin."